Drugmaker Genzyme has sold two Framingham office buildings for about $20.5 million. The company has had operations in Framingham for decades and has said it's committed to keeping a presence in ...

In the process, Genzyme Framingham won the EPA’s coveted WasteWise Partner of the Year Award in 2004, one of many environmental honors that the Massachusetts-based biotech company has earned ...

FRAMINGHAM — Sanofi Genzyme is doubling down on its investment in the Framingham Technology Park. The drug maker plans to increase the size of its ongoing expansion project in Framingham with a ...

FRAMINGHAM, MA-Genzyme Corp., a Cambridge-based biotech company, acquired a 70, 000-sf protein manufacturing facility in Belgium, and has decided to suspend its plan to develop a protein ...

Framingham is where Genzyme last year opened a $330 million manufacturing plant, in part using a $14.3 million grant from the state-created Massachusetts Life Sciences Center – the quasi-public ...

Genzyme says it has polished its manufacturing act. The company is poised to boost production of its costly treatment for Pompe disease, provided FDA finally gives its blessing to a new production ...

Biotechnology researcher Genzyme Corp. broke ground Wednesday on a $124 million, 177,00-square-foot facility in Framingham, Mass. The new site will consist of a six-story research facility and a ...

Genzyme's manufacturing improvements continue to pay off, allowing it to return to the market with a full supply of its thyroid cancer treatment, Thyrogen.

The International Brotherhood of Electrical Workers Local 103, a large local union, brought its campaign against the state's biotech bill to Genzyme Corp.'s campus here yesterday.

Genzyme (GENZ) says it will double the size of its newest Massachusetts manufacturing facility in Framingham, Massachusetts to nearly 2 million square feet over the next ten years, expanding on a ...